← Leaderboards
Hui Zong
University Of Virginia
$7,210,772
Attributed
$8,887,298
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2009–25$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,887,298 · 9
By mechanism
R01$6,523,854 · 3
R21$1,701,293 · 4
R25$562,151 · 1
R55$100,000 · 1
Top collaborators
- Kevin A Janes8 shared
- Janet V Cross1 shared
- Adrian J Halme1 shared
Most similar at University Of Virginia
Same institution · by research overlap
- Kevin A Janes$15,012,538
- Shayna Lefrak Showalter$2,294,427
- Harald W Sontheimer$24,930,190
- Ted M. Burns$821,116
- Noelle D Dwyer$7,701,237
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsMalignant NeoplasmsMutantGeneticLabelCell TypeTumorTumor InitiationNeoplastic CellIn VivoBaseLeadPremalignantResolutionGenesTissuesTreatment StrategyTumor Suppressor ProteinsMouse ModelTumorigenesisPreventPathway InteractionsProgenitorSignal Transduction
Grant awards (34)
A premalignant chronology of cell-state variability in basal-like breast cancer$655,486
R01 · FY2025 · CA
Summer Research Experience in Cancer(SuRE-C)$284,757
R25 · FY2025 · CA · contact PI
Elucidate the role of B/T cell-enriched immune aggregates in immune surveillance against TNBC$226,504
R21 · FY2025 · CA · contact PI
A premalignant chronology of cell-state variability in basal-like breast cancer$39,913
R01 · FY2025 · CA
A premalignant chronology of cell-state variability in basal-like breast cancer$622,712
R01 · FY2024 · CA
Summer Research Experience in Cancer(SuRE-C)$277,394
R25 · FY2024 · CA · contact PI
A premalignant chronology of cell-state variability in basal-like breast cancer$68,912
R01 · FY2024 · CA
A premalignant chronology of cell-state variability in basal-like breast cancer$642,376
R01 · FY2023 · CA
A premalignant chronology of cell-state variability in basal-like breast cancer$71,088
R01 · FY2023 · CA
A premalignant chronology of cell-state variability in basal-like breast cancer$655,486
R01 · FY2022 · CA
Discover the signaling basis for OPC homeostasis$453,110
R21 · FY2022 · NS · contact PI
A premalignant chronology of cell-state variability in basal-like breast cancer$34,928
R01 · FY2022 · CA
Deconstruct tumor microenvironment in medulloblastoma$364,837
R01 · FY2020 · NS · contact PI
Deconstruct tumor microenvironment in medulloblastoma$364,837
R01 · FY2019 · NS · contact PI
Establish a zebrafish genetic mosaic system for disease modeling and developmental biology$242,250
R21 · FY2019 · OD · contact PI
Establish a zebrafish genetic mosaic system for disease modeling and developmental biology$145,424
R21 · FY2019 · OD · contact PI
Deconstruct tumor microenvironment in medulloblastoma$426,672
R01 · FY2018 · NS · contact PI
Establish a zebrafish genetic mosaic system for disease modeling and developmental biology$201,875
R21 · FY2018 · OD · contact PI
Deconstruct tumor microenvironment in medulloblastoma$429,572
R01 · FY2017 · NS · contact PI
Deconstruct tumor microenvironment in medulloblastoma$30,841
R01 · FY2017 · NS · contact PI
Deconstruct tumor microenvironment in medulloblastoma$376,260
R01 · FY2016 · NS · contact PI
Characterizing the glioma cell of origin in vivo using MADM, a mouse genetic mosa$60,458
R01 · FY2015 · CA · contact PI
Characterizing the glioma cell of origin in vivo using MADM, a mouse genetic mosa$330,146
R01 · FY2014 · CA · contact PI
Highly specific, temporally controllable mouse genetic tools for investigating in$234,630
R21 · FY2014 · NS · contact PI
Characterizing the glioma cell of origin in vivo using MADM, a mouse genetic mosa$57,237
R01 · FY2014 · CA · contact PI
Characterizing the glioma cell of origin in vivo using MADM, a mouse genetic mosa$319,935
R01 · FY2013 · CA · contact PI
Highly specific, temporally controllable mouse genetic tools for investigating in$197,500
R21 · FY2013 · NS · contact PI
Characterizing the glioma cell of origin in vivo using MADM, a mouse genetic mosa$59,329
R01 · FY2013 · CA · contact PI
Characterizing the glioma cell of origin in vivo using MADM, a mouse genetic mosa$274,495
R01 · FY2012 · CA · contact PI
Characterizing the glioma cell of origin in vivo using MADM, a mouse genetic mosa$61,987
R01 · FY2012 · CA · contact PI
Characterizing the glioma cell of origin in vivo using MADM, a mouse genetic mosa$25,807
R01 · FY2012 · CA · contact PI
Characterizing the glioma cell of origin in vivo using MADM, a mouse genetic mosa$305,890
R01 · FY2011 · CA · contact PI
Characterizing the glioma cell of origin in vivo using MADM, a mouse genetic mosa$244,650
R01 · FY2010 · CA · contact PI
Modeling glioma with sporadic co-LOH of p53 and NF1 using a mouse genetic mosaic$100,000
R55 · FY2009 · CA · contact PI